Report Scope & Overview:
The Cardiovascular Information System Market Size was valued at USD 8.20 billion in 2022 and is expected to reach USD 14.96 billion by 2030, and grow at a CAGR of 7.8% over the forecast period 2023-2030.
The term "cardiovascular information system" (CVIS) refers to a system that makes it simple to create and distribute reports and provides timely access to cardiovascular electronic medical records (EMR) in the form of images, reports, and waveforms. Electrocardiography (ECG) data management, vascular solutions, catheterization, and echocardiography—all use CVIS.
To get more information on Cardiovascular Information System Market - Request Sample Report
Cardiology information system, or CIS, is a database that uses different types of software to compile clinical data. This data is gathered digitally using the software. It assists the users in making decisions of all kinds, advances science, and promotes information sharing in the field of cardiology. Because of the system's dependability, the data it offers, and the photos it stores in the reports, demand for cardiovascular information systems has increased in recent years. The data is kept in a way that makes it easier and more effective to offer patient reports.
The evolving nature of these technologies has increased the demand for cardiovascular information systems. The increase in chronic cardiovascular disease in developing countries over the past few years has been a major source of concern. The use of cardiovascular information systems would better manage patient data and help health care professionals identify patients more accurately due to the prevalence of such cases of CVD, which produces large amounts of data that are difficult to manage manually. These features will assist the Cardiovascular System Market in achieving a high CAGR soon.
Cardiovascular Diseases Are Becoming More Common and Incident
Concentrate on Improving Operational Efficiency and Lowering Medication Error Rates in Developed Markets
Healthcare Providers Are Able to Cut Costs by Implementing CVIS
Pricey CVIS Solutions
Healthcare Professionals' Resistance to CVIS Implementation
Solutions Using the Cloud
Solutions from CVIS are integrated and interoperable.
IMPACT OF COVID-19
The need for medical supplies is growing as a result of the afflicted population. One of the most common medical devices in first-line clinical therapy is a respiratory support equipment, such as an oxygen generator, life-support system, or monitor. A significant increase in demand for medical products including masks, gloves, and protective eyewear has also been brought on by COVID-19. Due to preventative measures, there is an increasing demand for medical supplies from both healthcare professionals and the general public due to an increase in COVID-19 cases around the world. In order to guarantee a sufficient and ongoing supply of personal protective equipment in the cardiac information system (CIS) industry, manufacturers of these items have the opportunity to take benefit from the expanding need for medical supplies.
Market segments include CVIS and CPACS. In comparison to CPACS, CVIS technologies enable clinicians to make appropriate therapeutic decisions faster and with greater efficiency. As a result, it was found that CVIS was adopted more frequently than CPACS. As a result, the CVIS segment had the biggest market share, and it is anticipated that it will continue to hold that position during the projected period.
The hardware, software, and service segments of the market are divided. The largest portion of the CVIS market was accounted for by the services category. The market's highest CAGR is being experienced by the service segment. The highest market share is anticipated to go to the software segment. The demand for CVIS integration with CPACS/EMR and other cardiology modules is one of the factors propelling the market expansion in this component segment.
By Mode of Operation
Web-based, Onsite, and Cloud-based products make up two halves of the market. The majority of the market was made up of web-based products. The widespread use of the web-based mode of operation for cardiovascular information systems around the world can be attributed in part to the high rate of awareness and the relatively lower cost. The market for this type of method of operation is expanding as a result of factors like improved interoperability, remote access to images and data, and reduced IT burden in hospitals due to web-based technology.
By End User
Diagnostic centers and hospitals make up the two segments of the market. The market's highest share is anticipated to go to the hospital sector. The market expansion in this end-user sector is being driven by the high adoption rate of CVIS solutions as a result of the substantial purchasing power of major hospitals.
Catheterization lab CVIS solutions, Electrophysiology lab CVIS solutions, Pacemaker / ICD lab CVIS solutions, Ecg / Holter monitoring lab CVIS solutions, Echocardiography lab CVIS solutions, Heart Failure Center CVIS solutions, Nuclear Cardiology CVIS solutions, and Cardiothoracic market solutions are different market CVIScic components.
KEY MARKET SEGMENTS
By Mode of Operation
By End User
Catheterization Lab CVIS Solutions
Echocardiography Lab CVIS Solutions
Electrophysiology Lab CVIS Solutions
Nuclear Cardiology CVIS Solutions
Cardiothoracic Center CVIS Solutions
ECG Studies/Holter monitoring CVIS Solutions
Pacemaker/ICD Lab CVIS Solutions
Heart Failure Centers CVIS Solutions
Outpatient Clinics CVIS Solutions
Need any customization research on Cardiovascular Information System Market - Enquiry Now
After the European region, the market for cardiovascular information systems has mostly extended to North American regions. Geographically, it has been noted that this area of North America is dominated by stringent privacy and security laws, and that the amount of commerce in the cardiovascular information sector is rising. The North American region has an international healthcare information system that has grown its vendor partnerships. Although Latin America is predicted to be less developed than other rising nations, there is still a significant opportunity for the market for cardiovascular information systems to grow during the time of market projection.
Rest of Europe
Rest of Asia-Pacific
The Middle East & Africa
Rest of Middle East & Africa
Rest of Latin America
Some of the major key players are Cerner Corporation, Esasote, CREALIFE Medical Technology, Fujifilm Medical Systems, GE Healthcare, Merge Healthcare Inc, Lumedx, Philips Healthcare, Simens Healthineers AG, McKesson Corporation and other players.
Merge Healthcare Inc-Company Financial Analysis
|Market Size in 2022
|US$ 8.20 Billion
|Market Size by 2030
|US$ 14.96 Billion
|CAGR of 7.8% From 2023 to 2030
|Report Scope & Coverage
|Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
|• By Type (CVIS, C-PACS)
• By Component (Software, Services, Hardware)
• By Mode of Operation (Web-based, Onsite, Cloud-based)
• By End User (Hospitals, Diagnostic Centers)
• By Application (Catheterization Lab CVIS Solutions, Echocardiography Lab CVIS Solutions, Electrophysiology Lab CVIS Solutions, Nuclear Cardiology CVIS Solutions, Cardiothoracic Center CVIS Solutions, ECG Studies/Holter monitoring CVIS Solutions, Pacemaker/ICD Lab CVIS Solutions, Heart Failure Centers CVIS Solutions, Outpatient Clinics CVIS Solutions)
|North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
|Cerner Corporation, Esasote, CREALIFE Medical Technology, Fujifilm Medical Systems, GE Healthcare, Merge Healthcare Inc, Lumedx, Philips Healthcare, Simens Healthineers AG, McKesson Corporation.
|• Cardiovascular Diseases Are Becoming More Common and Incident
• Concentrate on Improving Operational Efficiency and Lowering Medication Error Rates in Developed Markets
• Healthcare Providers Are Able to Cut Costs by Implementing CVIS
|• Pricey CVIS Solutions
• Healthcare Professionals' Resistance to CVIS Implementation
Ans: The Cardiovascular Information System Market Size was valued at USD 8.20 billion in 2022.
Ans: The Cardiovascular Information System Market size is growing at a CAGR of 7.8% over the forecast period 2023-2030.
Cerner Corporation, Esasote, CREALIFE Medical Technology, Fujifilm Medical Systems, GE Healthcare, Merge Healthcare Inc, are the key players of Cardiovascular Information System market
North America is dominated by stringent privacy and security laws, and that the amount of commerce in the cardiovascular information sector is rising.
Cardiovascular Diseases Are Becoming More Common and Incident, Concentrate on Improving Operational Efficiency and Lowering Medication Error being the key drivers of the Cardiovascular Information System market.
Table of Contents
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.2 Impact on major economies
220.127.116.11 United Kingdom
18.104.22.168 South Korea
22.214.171.124 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Cardiovascular Information System Market Segmentation, By Type
9. Cardiovascular Information System Market Segmentation, By Component
10. Cardiovascular Information System Market Segmentation, By Mode of Operation
11. Cardiovascular Information System Market Segmentation, By End User
11.2 Diagnostic Centers
12. Cardiovascular Information System Market Segmentation, By Application
12.1 Catheterization Lab CVIS Solutions
12.2 Echocardiography Lab CVIS Solutions
12.3 Electrophysiology Lab CVIS Solutions
12.4 Nuclear Cardiology CVIS Solutions
12.5 Cardiothoracic Center CVIS Solutions
12.6 ECG Studies/Holter monitoring CVIS Solutions
12.7 Pacemaker/ICD Lab CVIS Solutions
12.8 Heart Failure Centers CVIS Solutions
12.9 Outpatient Clinics CVIS Solutions
13. Regional Analysis
13.2 North America
13.3.6 The Netherlands
13.3.7 Rest of Europe
13.4.2 South Korea
13.4.6 Rest of Asia-Pacific
13.5 The Middle East & Africa
13.5.3 South Africa
13.6 Latin America
13.6.3 Rest of Latin America
14. Company Profiles
14.1 Cerner Corporation
14.1.2 Products/ Services Offered
14.1.3 SWOT Analysis
14.1.4 The SNS view
14.3 CREALIFE Medical Technology
14.4 Fujifilm Medical Systems
14.5 GE Healthcare
14.6 Merge Healthcare Inc
14.8 Philips Healthcare
14.9 Simens Healthineers AG
14.10 McKesson Corporation.
15. Competitive Landscape
15.1 Competitive Benchmark
15.2 Market Share Analysis
15.3 Recent Developments
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Healthcare Education Market Size was valued at USD 98.58 billion in 2022, and is expected to reach USD 190.74 billion by 2030 and grow at a CAGR of 8.6% over the forecast period 2023-2030.
The Urinary Drainage Bags Market size was valued at USD 2.03 billion in 2022 and it is expected to be worth around USD 2.95 billion by 2030 growing at a remarkable GAGR of 4.8% over the forecast period 2023-2030.
In 2022, The Medical Mask Market size amounted to USD 2.42 Billion & is estimated to reach USD 4.57 Billion by 2030 and increase at a compound annual growth rate of 8.3% between 2023 and 2030.
The Anticoagulation Market Size was valued at USD 35.25 billion in 2022, and is expected to reach USD 61.49 billion by 2030 and grow at a CAGR of 7.9% over the forecast period 2023-2030.
In 2022, The Cardiac Biomarkers Market size amounted to USD 15.87 Billion & is estimated to reach USD 48.21 Billion by 2030 and increase at a compound annual growth rate of 14.9% between 2023 and 2030.
The Nebulizer Market was estimated at USD 1.08 billion in 2022 and is poised to reach at 1.72 billion in 2030 anticipated to expand at a compound annual growth rate approx. CAGR of 6% for the forecast period of 2023-2030.
Hi! Click one of our member below to chat on Phone